|
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for multiple sclerosis.
Reviewed September 2009
Printer friendly page
| Results 1 to 20 displayed. |
|
1
2
|
| Title: |
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Relapsing-remitting MS is characterised by periods of disability due to inflammation in the central nervous system. These episodes are called relapses. All research has shown that a speed up recovery is obtained by corticosteroids, given most often in i...
|
| Date: |
Aug 2008
|
| Title: |
Interferon beta for primary progressive multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
To date there is no proven or licensed disease-modifying treatments to slow the progression of PPMS. Studies on the effects of INF beta have mainly focused on Relapsing-Remitting MS and have demonstrated a modest reduction on the progression of the dis...
|
| Date: |
Apr 2008
|
| Title: |
Treatment of seizures in multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Epileptic seizures occur in a relatively small number of patients with multiple sclerosis, but can have serious consequences. Because the cause of epileptic seizures in patients in MS may be different from that in other forms of epilepsy, it is uncertai...
|
| Date: |
Feb 2008
|
| Title: |
Anticholinergics for urinary symptoms in multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Urinary symptoms are very common in people with multiple sclerosis, reflecting the high prevalence of damage to the spinal cord from MS. Symptoms may change with time due to either progression or MS relapses. Common symptoms include frequency, urgency a...
|
| Date: |
Jan 2008
|
| Title: |
Methotrexate for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis (MS) is an immune disease of the nervous system. Drugs that interfere with the immune system, such as methotrexate could benefit people with the disease. To date research suggest that there may be small improvements from treatment wit...
|
| Date: |
Oct 2007
|
| Title: |
Corticosteroids for the long-term treatment in multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis is an inflammatory disease affecting the brain and spinal cord. It results in episodes of neurological deficit which recover (relapses) as well as accumulation of sustained disability with the passage of time. Corticosteroids are pote...
|
| Date: |
Aug 2007
|
| Title: |
Azathioprine for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
AZA is a possible alternative to interferon beta for treating MS. As concerns have been raised about its safety, mainly due to possible increased risk of cancer, the authors of this review tried to assess the balance between benefits and harms of AZA tr...
|
| Date: |
May 2007
|
| Title: |
Interferon in relapsing-remitting multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. Repeated damage to the myelin sheaths and other parts of the nerves can lead to serious disability. MS may be related to the immune system. In...
|
| Date: |
Apr 2007
|
| Title: |
Cyclophosphamide for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
MS is a chronic disease of the nervous system affecting young and middle-aged adults. MS is supposed to be related to the immune system. CFX is an immunosuppressive drug used for various autoimmune diseases. As its use for MS is controversial, the Autho...
|
| Date: |
Nov 2006
|
| Title: |
Amantadine for fatigue in multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis (MS) is a chronic disease affecting young and middle-aged adults. One of the most common and disabling symptoms of MS is fatigue. Different approaches have been used to try and improve this, including energy conservation, specialised ...
|
| Date: |
Nov 2006
|
| Title: |
Treatment for ataxia in multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
MS is a chronic disease of the central nervous system which typically affects both young and middle aged adults. It can result in many different symptoms including ataxia....
|
| Date: |
Aug 2006
|
| Title: |
Dietary interventions for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Because available conventional treatments are only partially effective and may produce side effects, most patients with MS use therapies proposed by complementary and alternative medicine - usually diets and dietary supplements. In fact, an Internet sea...
|
| Date: |
Aug 2006
|
| Title: |
Hyperbaric oxygen therapy for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. Repeated damage to parts of the nerves leads to progressive weakness and disability. Hyperbaric oxygen therapy (HBOT) involves people breathin...
|
| Date: |
Jun 2006
|
| Title: |
Multidisciplinary rehabilitation for adults with multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis is a chronic neurological condition, which can cause multiple disabilities and limit participation in young adults. This review looked for evidence of MD rehabilitation in adults with multiple sclerosis. The authors concluded there wa...
|
| Date: |
Jun 2006
|
| Title: |
Mitoxantrone for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
MS is an immune-mediated chronic disorder of the central nervous system (CNS) characterized by multiple areas of inflammation and demyelination. MS is among the commonest causes of neurological disability in young people. Steroids, interferon and other ...
|
| Date: |
Aug 2005
|
| Title: |
Psychological interventions for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
In many countries MS is the most common neurological disorder among young adults. Its impact can be overwhelming with the person facing the likelihood of reduced physical function and of disability, with consequent disruptions in education, employment, ...
|
| Date: |
May 2005
|
| Title: |
Therapy with glatiramer acetate for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults and can lead to permanent disability. MS damages several parts of the nerves, including the myelin sheath. Glatiramer acetate (Copaxone <) is a...
|
| Date: |
Dec 2004
|
| Title: |
Aminopyridines for symptomatic treatment in multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Multiple sclerosis (MS) is a disease that affects young and middle-aged adults, causing different symptoms in individuals. It is caused by damage to the myelin sheaths (fibres that wrap around and protect the nerves and spinal cord). Potassium (a minera...
|
| Date: |
Dec 2004
|
| Title: |
Exercise therapy for multiple sclerosis
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
MS is a chronic disease of the central nervous system. The variable distribution of the damage in the myelin sheath of nerves may lead to loss of strength, sensation, co-ordination and balance causing severe and progressive limitations of function in da...
|
| Date: |
Mar 2004
|
| Results 1 to 20 displayed. |
|
1
2
|
|